Sara J. Hooshmand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sara J. Hooshmand has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- John J. Chen
Department of Neurology and Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN
2 shared publications - Rafid Mustafa
Department of Neurology, Mayo Clinic, Rochester, MN, USA
2 shared publications Ajay A. Madhavan
Mayo Clinic College of Medicine & Science
1 shared publication- Alfonso Sebastian Lopez Chiriboga
Department of Neurology Mayo Clinic Jacksonville Florida USA
1 shared publication Andrea A. Tooley
Department of Ophthalmology, Mayo Clinic (T.T.X., A.A.T., A.J.B., J.J.C.), Rochester, Minnesota, USA
1 shared publication- Andrew J. Barkmeier
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota
1 shared publication
Latest Publications
- Open Access
- 2 December 2025
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 15 (1) , 59
Chorea After MR-Guided Focused Ultrasound Thalamotomy
Background: Magnetic resonance-guided focused ultrasound thalamotomy (MR-FUS) is a promising, noninvasive treatment for medically refractory essential tremor (ET). It is well tolerated, with the most common side effects being sensory and gait disturbances. Case Report: A 69-year-old man presented with orofacial dyskinesias, left hemichorea, and motor impersistence 1 week after MR-FUS of the right ventralis intermedius nucleus for ET. MRI brain demonstrated right ventral thalamus T2 hyperintensity with inferolateral extension abutting the subthalamic nucleus (STN). Discussion: Chorea is a rare side effect of MR-FUS, but may be present with inferolateral lesions extension to the STN, disrupting the indirect pathway.
- 2 December 2025
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 15 (1) , 59
Open AccessChorea After MR-Guided Focused Ultrasound Thalamotomy
Background: Magnetic resonance-guided focused ultrasound thalamotomy (MR-FUS) is a promising, noninvasive treatment for medically refractory essential tremor (ET). It is well tolerated, with the most common side effects being sensory and gait disturbances. Case Report: A 69-year-old man presented with orofacial dyskinesias, left hemichorea, and motor impersistence 1 week after MR-FUS of the right ventralis intermedius nucleus for ET. MRI brain demonstrated right ventral thalamus T2 hyperintensity with inferolateral extension abutting the subthalamic nucleus (STN). Discussion: Chorea is a rare side effect of MR-FUS, but may be present with inferolateral lesions extension to the STN, disrupting the indirect pathway.
- 16 November 2025
- Published by SAGE Publications in The Neurohospitalist
- Vol. 16 (3) , 280-285
The Role of Trendelenburg Positioning for the Acute Symptomatic Management of Spontaneous Intracranial Hypotension
Background: Spontaneous intracranial hypotension (SIH) results from cerebrospinal fluid (CSF) leakage due to spinal dural tears or CSF–venous fistulas. Orthostatic headache is the hallmark presentation, though severe downward displacement of the brainstem may lead to altered consciousness or coma. Definitive treatments include targeted epidural blood patches, venous embolization, or surgical repair. Methods: This article reviews the role of the Trendelenburg position as a temporizing measure in the acute management of SIH. We describe the correct technique, physiologic rationale, and practical considerations for its application, with attention to both therapeutic and diagnostic utility. Discussion: Positioning the patient with the feet elevated above the head can reduce brain sag and provide short-term symptomatic relief while awaiting definitive treatment. Although the Trendelenburg position is widely used in practice, supporting evidence remains limited, and clinicians must be aware of its benefits, indications, and inherent limitations. Its appropriate application may assist in stabilizing patients with acute or severe SIH, particularly those with impaired consciousness, until more definitive interventions are pursued.
- 16 November 2025
- Published by SAGE Publications in The Neurohospitalist
- Vol. 16 (3) , 280-285
The Role of Trendelenburg Positioning for the Acute Symptomatic Management of Spontaneous Intracranial Hypotension
Background: Spontaneous intracranial hypotension (SIH) results from cerebrospinal fluid (CSF) leakage due to spinal dural tears or CSF–venous fistulas. Orthostatic headache is the hallmark presentation, though severe downward displacement of the brainstem may lead to altered consciousness or coma. Definitive treatments include targeted epidural blood patches, venous embolization, or surgical repair. Methods: This article reviews the role of the Trendelenburg position as a temporizing measure in the acute management of SIH. We describe the correct technique, physiologic rationale, and practical considerations for its application, with attention to both therapeutic and diagnostic utility. Discussion: Positioning the patient with the feet elevated above the head can reduce brain sag and provide short-term symptomatic relief while awaiting definitive treatment. Although the Trendelenburg position is widely used in practice, supporting evidence remains limited, and clinicians must be aware of its benefits, indications, and inherent limitations. Its appropriate application may assist in stabilizing patients with acute or severe SIH, particularly those with impaired consciousness, until more definitive interventions are pursued.
- 9 September 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (5) , e214081
Teaching NeuroImage: Female Hormonal Therapy and Cerebral Cavernous Malformation Hemorrhage
- 9 September 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (5) , e214081
Teaching NeuroImage: Female Hormonal Therapy and Cerebral Cavernous Malformation Hemorrhage
- 19 August 2025
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 31 (14) , 1629-1640
Application of the ADEM definition to cerebral attacks of MOG antibody-associated disease
Background: Acute disseminated encephalomyelitis (ADEM) is a demyelinating syndrome observed in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) but there are limited data on application of this definition to its cerebral attacks or in adults with this disease. Methods: We analyzed patients from the Mayo Clinic MOGAD cohort ( n = 263) with cerebral attacks. We assessed whether children (<18 years-old) and adults (⩾18 years-old) fulfilled the 2013 ADEM definition. Results: We identified 89 patients (children, 34; adults, 55) and 55/89 (62%) were of female sex. Acute magnetic resonance imaging (MRI) abnormalities included: poorly demarcated T2 lesions (white matter, 85 (96%); deep gray matter, 41 (46%); T1-hypointense lesions (42 (47%)). Forty-two patients did not fulfill the ADEM definition due to: monofocal syndrome, 9; or no encephalopathy, 33. The remaining 47 patients (53%: children, 27/34 (79%); adults, 20/55 (36%)) fulfilled the ADEM definition, and 14 had preceding attacks, and 34 had subsequent attacks relative to ADEM episode. The features in children and adults with ADEM were broadly comparable. Conclusion: Applying the ADEM definition to MOGAD cerebral attacks highlighted that an update of the 2013 ADEM definition would be beneficial and could explicitly state its application to both adults and children and allow it to be applied to attacks at any time during the disease course.
- 19 August 2025
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 31 (14) , 1629-1640
Application of the ADEM definition to cerebral attacks of MOG antibody-associated disease
Background: Acute disseminated encephalomyelitis (ADEM) is a demyelinating syndrome observed in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) but there are limited data on application of this definition to its cerebral attacks or in adults with this disease. Methods: We analyzed patients from the Mayo Clinic MOGAD cohort ( n = 263) with cerebral attacks. We assessed whether children (<18 years-old) and adults (⩾18 years-old) fulfilled the 2013 ADEM definition. Results: We identified 89 patients (children, 34; adults, 55) and 55/89 (62%) were of female sex. Acute magnetic resonance imaging (MRI) abnormalities included: poorly demarcated T2 lesions (white matter, 85 (96%); deep gray matter, 41 (46%); T1-hypointense lesions (42 (47%)). Forty-two patients did not fulfill the ADEM definition due to: monofocal syndrome, 9; or no encephalopathy, 33. The remaining 47 patients (53%: children, 27/34 (79%); adults, 20/55 (36%)) fulfilled the ADEM definition, and 14 had preceding attacks, and 34 had subsequent attacks relative to ADEM episode. The features in children and adults with ADEM were broadly comparable. Conclusion: Applying the ADEM definition to MOGAD cerebral attacks highlighted that an update of the 2013 ADEM definition would be beneficial and could explicitly state its application to both adults and children and allow it to be applied to attacks at any time during the disease course.
- 4 October 2024
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 269, 393-401
Outcomes of Hyperbaric Oxygen Treatment for Central Retinal Artery Occlusion: A Single Center Experience
- 4 October 2024
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 269, 393-401
Outcomes of Hyperbaric Oxygen Treatment for Central Retinal Artery Occlusion: A Single Center Experience
- 24 September 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 103 (6)
Teaching Video NeuroImage: Isolated Presentation of Cavernous Sinus Syndrome From CNS Lymphoma
- 24 September 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 103 (6)
Teaching Video NeuroImage: Isolated Presentation of Cavernous Sinus Syndrome From CNS Lymphoma
- 21 November 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 101 (21) , E2204
Teaching Video NeuroImage: Response to IVIg in a Patient With Steroid-Refractory Immune Checkpoint Inhibitor–Related Ocular Myopathy
- 21 November 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 101 (21) , E2204
Teaching Video NeuroImage: Response to IVIg in a Patient With Steroid-Refractory Immune Checkpoint Inhibitor–Related Ocular Myopathy
- Open Access
- 31 May 2023
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 16 (2) , 196-201
Sex and Gender Influence Urinary Symptoms and Management in Multiple System Atrophy
Objective Multiple system atrophy (MSA) is characterized by urinary dysfunction, yet the influence of sex and gender on urinary symptoms and treatment is unclear. We sought to characterize sex and gender differences in the symptomatology, evaluation, and management of urinary dysfunction in patients with MSA.Methods Patients with MSA evaluated at our institution were reviewed and stratified by sex.Results While the prevalence of urinary symptoms was similar in male and female patients, incontinence was more common in females. Despite this, males and females underwent postvoid residual (PVR) measurement at similar rates. While catheterization rates were similar when PVR was measured, males were more than twice as likely to be catheterized than females in the absence of PVR measurement.Conclusion Urinary symptoms are common in MSA, but their presentation differs between males and females. The difference in catheterization rates may be driven by a gender disparity in referrals for PVR, which can guide treatment.
- 31 May 2023
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 16 (2) , 196-201
Open AccessSex and Gender Influence Urinary Symptoms and Management in Multiple System Atrophy
Objective Multiple system atrophy (MSA) is characterized by urinary dysfunction, yet the influence of sex and gender on urinary symptoms and treatment is unclear. We sought to characterize sex and gender differences in the symptomatology, evaluation, and management of urinary dysfunction in patients with MSA.Methods Patients with MSA evaluated at our institution were reviewed and stratified by sex.Results While the prevalence of urinary symptoms was similar in male and female patients, incontinence was more common in females. Despite this, males and females underwent postvoid residual (PVR) measurement at similar rates. While catheterization rates were similar when PVR was measured, males were more than twice as likely to be catheterized than females in the absence of PVR measurement.Conclusion Urinary symptoms are common in MSA, but their presentation differs between males and females. The difference in catheterization rates may be driven by a gender disparity in referrals for PVR, which can guide treatment.
- 1 March 2023
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 98 (3) , 468-473
40-Year-Old Man with Dysphagia
- 1 March 2023
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 98 (3) , 468-473
40-Year-Old Man with Dysphagia
- Open Access
- 1 January 2022
- Published by SAGE Publications in Therapeutic Advances in Ophthalmology
- Vol. 14
Outcomes of initial and repeat micro-pulse transscleral cyclophotocoagulation in adult glaucoma patients
Background: Micro-pulse transscleral cyclophotocoagulation (MP-TSCPC) has continued to gain popularity as a treatment in adult glaucoma patients. Thus far there is limited evidence reporting the efficaciousness and safety of retreatment. Objective: To evaluate safety and efficacy of primary and repeat MP-TSCPC procedures. Methods: Thirty-four of 67 eyes who failed to achieve target IOP from initial MP-TSCPC underwent repeat MP-TSCPC and followed for a minimum of 6 months. All treatments were performed using the laser power of 2000 or 2250 mW, duration of 100–200 s, and a velocity 16–20 s per hemisphere swipe. Success criteria were defined as intraocular pressure (IOP) reduction of greater than 20% from baseline or any medication reduction without additional glaucoma procedures at 6 months after repeat MP-TSCPC. The 6-month success rate after repeat MP-TSCPC was also compared to that of initial MP-TSCPC in the same group of eyes. Results: Mean baseline IOP before the repeat MP-TSCPC was 23.0 + /- 5.3 on 3.0 + /- 1.4 medications. At 6 months, mean post-op IOP was 18.2 + /- 5.4 (21.9% reduction, p < 0.002), with mean medication staying relatively the same ( p = .976). Success rate was increased from 23.5% to 44.1% with the repeat procedure compared to that of initial procedure ( p = 0.123). Mean IOP reduction was also greater after repeat MP-TSCPC (18.7%, p < 0.002) when compared to initial MP-TSCPC (10.4%). No adverse events occurred. Conclusions: MP-TSCPC is a safe and effective non-invasive means to lower IOP in a variety of glaucoma patients. While over 50% (34/67) of eyes required repeat MP-TSCPC, repeat treatment resulted in greater success rates and IOP reduction without any adverse events when using the total energy between 112 and 150 J.
- 1 January 2022
- Published by SAGE Publications in Therapeutic Advances in Ophthalmology
- Vol. 14
Open AccessOutcomes of initial and repeat micro-pulse transscleral cyclophotocoagulation in adult glaucoma patients
Background: Micro-pulse transscleral cyclophotocoagulation (MP-TSCPC) has continued to gain popularity as a treatment in adult glaucoma patients. Thus far there is limited evidence reporting the efficaciousness and safety of retreatment. Objective: To evaluate safety and efficacy of primary and repeat MP-TSCPC procedures. Methods: Thirty-four of 67 eyes who failed to achieve target IOP from initial MP-TSCPC underwent repeat MP-TSCPC and followed for a minimum of 6 months. All treatments were performed using the laser power of 2000 or 2250 mW, duration of 100–200 s, and a velocity 16–20 s per hemisphere swipe. Success criteria were defined as intraocular pressure (IOP) reduction of greater than 20% from baseline or any medication reduction without additional glaucoma procedures at 6 months after repeat MP-TSCPC. The 6-month success rate after repeat MP-TSCPC was also compared to that of initial MP-TSCPC in the same group of eyes. Results: Mean baseline IOP before the repeat MP-TSCPC was 23.0 + /- 5.3 on 3.0 + /- 1.4 medications. At 6 months, mean post-op IOP was 18.2 + /- 5.4 (21.9% reduction, p < 0.002), with mean medication staying relatively the same ( p = .976). Success rate was increased from 23.5% to 44.1% with the repeat procedure compared to that of initial procedure ( p = 0.123). Mean IOP reduction was also greater after repeat MP-TSCPC (18.7%, p < 0.002) when compared to initial MP-TSCPC (10.4%). No adverse events occurred. Conclusions: MP-TSCPC is a safe and effective non-invasive means to lower IOP in a variety of glaucoma patients. While over 50% (34/67) of eyes required repeat MP-TSCPC, repeat treatment resulted in greater success rates and IOP reduction without any adverse events when using the total energy between 112 and 150 J.